HawaiiSB 20472025–2026 Regular Session (Year 2)Senate

RELATING TO PHARMACY BENEFIT MANAGERS.

Sponsored By: Jarrett Keohokalole (Democratic)

Passed

Summary

Establishes certain requirements for pharmacy benefit managers, other than health maintenance organizations that own and operate their own pharmacies, that reimburse contracting pharmacies for drugs on a maximum allowable cost basis. Allows contracting pharmacies to reverse and rebill claims if a maximum allowable cost is denied on appeal. Authorizes the Insurance Commissioner to assess fines for violations. Appropriates funds. Effective 7/1/3000. (HD2)

Insurance CommissionerPharmacy Benefit ManagersPrescription DrugsMaximum Allowable CostContracting PharmaciesAppropriationHLT, CPC, FIN

Your PRIA Score

Score Hidden

Personalized for You

How does this bill affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Bill Overview

No Economic Impacts Identified for this Bill

Sponsors & Cosponsors

Sponsor

  • Jarrett Keohokalole

    Democratic • Senate

Cosponsors

  • Stanley Chang

    Democratic • Senate

  • Kurt Fevella

    Republican • Senate

  • Angus L.K. McKelvey

    Democratic • Senate

  • III Richards

    Democratic • Senate

  • Joy A. San Buenaventura

    Democratic • Senate

Roll Call Votes

All Roll Calls

Yes: 96 • No: 0

House vote 3/20/2026

Passed Second Reading as amended in HD 1 and referred to the committee(s) on CPC...

Yes: 50 • No: 0

Senate vote 3/10/2026

Senate Floor Vote

Yes: 25 • No: 0

Senate vote 3/3/2026

The committee(s) on CPN recommend(s) that the measure be PASSED, WITH AMENDMENT...

Yes: 4 • No: 0

Senate vote 3/3/2026

The committee(s) on WAM recommend(s) that the measure be PASSED, WITH AMENDMENT...

Yes: 12 • No: 0

Senate vote 2/2/2026

The committee(s) on HHS recommend(s) that the measure be PASSED, WITH AMENDMENT...

Yes: 5 • No: 0

Actions Timeline

  1. Reported from CPC (Stand. Com. Rep. No. 1483-26) as amended in HD 2, recommending referral to FIN.

    3/30/2026House
  2. Report adopted; referred to the committee(s) on FIN as amended in HD 2 with none voting aye with reservations; none voting no (0) and Representative(s) Cochran, Lowen, Perruso, Quinlan excused (4).

    3/30/2026House
  3. The committee on CPC recommend that the measure be PASSED, WITH AMENDMENTS. The votes were as follows: 11 Ayes: Representative(s) Matayoshi, Grandinetti, Chun, Ilagan, Ichiyama, Iwamoto, Kong, Lowen, Marten, Tam, Pierick; Ayes with reservations: none; Noes: none; and Excused: none.

    3/24/2026House
  4. Reported from HLT (Stand. Com. Rep. No. 1278-26) as amended in HD 1, recommending passage on Second Reading and referral to CPC.

    3/20/2026House
  5. Passed Second Reading as amended in HD 1 and referred to the committee(s) on CPC with none voting aye with reservations; none voting no (0) and Representative(s) Quinlan excused (1).

    3/20/2026House
  6. Bill scheduled to be heard by CPC on Tuesday, 03-24-26 2:00PM in House conference room 329 VIA VIDEOCONFERENCE.

    3/20/2026House
  7. The committee on HLT recommend that the measure be PASSED, WITH AMENDMENTS. The votes were as follows: 8 Ayes: Representative(s) Takayama, Keohokapu-Lee Loy, Amato, Marten, Olds, Takenouchi, Alcos, Garcia; Ayes with reservations: none; Noes: none; and 1 Excused: Representative(s) Hartsfield.

    3/18/2026House
  8. Pass First Reading

    3/12/2026House
  9. Referred to HLT, CPC, FIN, referral sheet 17

    3/12/2026House
  10. Bill scheduled to be heard by HLT on Wednesday, 03-18-26 9:00AM in House conference room 329 VIA VIDEOCONFERENCE.

    3/12/2026House
  11. Report adopted; Passed Third Reading, as amended (SD 2). Ayes, 25; Aye(s) with reservations: none . Noes, 0 (none). Excused, 0 (none). Transmitted to House.

    3/10/2026Senate
  12. Received from Senate (Sen. Com. No. 156) in amended form (SD 2).

    3/10/2026House
  13. Reported from CPN/WAM (Stand. Com. Rep. No. 2918) with recommendation of passage on Third Reading, as amended (SD 2).

    3/6/2026Senate
  14. 48 Hrs. Notice 03-10-26.

    3/6/2026Senate
  15. The committee(s) on CPN recommend(s) that the measure be PASSED, WITH AMENDMENTS. The votes in CPN were as follows: 4 Aye(s): Senator(s) Keohokalole, Fukunaga, Lamosao, McKelvey; Aye(s) with reservations: none ; 0 No(es): none; and 1 Excused: Senator(s) Awa.

    3/3/2026Senate
  16. The committee(s) on WAM recommend(s) that the measure be PASSED, WITH AMENDMENTS. The votes in WAM were as follows: 12 Aye(s): Senator(s) Dela Cruz, Moriwaki, DeCoite, Elefante, Hashimoto, Inouye, Kanuha, Kidani, Kim, Lee, C., Richards, Wakai; Aye(s) with reservations: none ; 0 No(es): none; and 1 Excused: Senator(s) Fevella.

    3/3/2026Senate
  17. The committee(s) on CPN/WAM will hold a public decision making on 03-03-26 10:16AM; Conference Room 211 & Videoconference.

    2/27/2026Senate
  18. Reported from HHS (Stand. Com. Rep. No. 2200) with recommendation of passage on Second Reading, as amended (SD 1) and referral to CPN/WAM.

    2/11/2026Senate
  19. Report adopted; Passed Second Reading, as amended (SD 1) and referred to CPN/WAM.

    2/11/2026Senate
  20. Re-Referred to HHS, CPN/WAM.

    2/3/2026Senate
  21. The committee(s) on HHS recommend(s) that the measure be PASSED, WITH AMENDMENTS. The votes in HHS were as follows: 5 Aye(s): Senator(s) San Buenaventura, McKelvey, Kanuha, Keohokalole, Fevella; Aye(s) with reservations: none ; 0 No(es): none; and 0 Excused: none.

    2/2/2026Senate
  22. The committee(s) on HHS has scheduled a public hearing on 02-02-26 1:05PM; Conference Room 225 & Videoconference.

    1/30/2026Senate
  23. Referred to HHS, CPN.

    1/22/2026Senate
  24. Introduced and passed First Reading.

    1/21/2026Senate
  25. Pending Introduction.

    1/14/2026Senate

Bill Text

Related Bills

Back to State Legislation